Clinical trial · Observational
Does a Minimally Invasive Approach to Liver Resection Improve Postoperative Outcomes?
NCT07169877CI-TRIAL-00095012completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
A retrospective cohort study was conducted using the American College of Surgeons National Surgical Quality Improvement Program (NSQIP) database to identify adult patients who underwent liver resection between 2022 and 2023. Primary outcomes included 30-day mortality, sepsis, septic shock, readmission, and reoperation.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hepatic Neoplasms | Liver Neoplasm | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- Participant who underwent liver resection
- description
- Adult patients who underwent liver resection between January 2022 and December 2023. Data obtained from the American College of Surgeons National Surgical Quality Improvement Program (NSQIP)
Primary outcomes (5)
- measure
- 30-day mortality
- timeFrame
- 30 days
- description
- Number of deaths at 30 days
- measure
- Number of participants with Sepsis
- timeFrame
- 30 days
- description
- Number of participants with sepsis at 30 days
- measure
- Number of participants with Septic Shock
- timeFrame
- 30 days
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: \- Retrospective patients with condition only Exclusion Criteria: \- none
References
Publications (0)
Data not yet available
No reference posted for this study.